S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The gold catalyst we’ve waited for (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The gold catalyst we’ve waited for (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The gold catalyst we’ve waited for (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The gold catalyst we’ve waited for (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
NASDAQ:GMVD

G Medical Innovations - GMVD Stock Forecast, Price & News

$1.98
+0.26 (+15.12%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.71
$2.19
50-Day Range
$1.72
$5.41
52-Week Range
$1.66
$57.05
Volume
61,738 shs
Average Volume
887,619 shs
Market Capitalization
$3.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

GMVD stock logo

About G Medical Innovations (NASDAQ:GMVD) Stock

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.

Receive GMVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for G Medical Innovations and its competitors with MarketBeat's FREE daily newsletter.

GMVD Stock News Headlines

Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
G Medical Innovations Up 83% on Heavy Volume
See More Headlines
Receive GMVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for G Medical Innovations and its competitors with MarketBeat's FREE daily newsletter.

GMVD Company Calendar

Today
3/25/2023
Next Earnings (Estimated)
4/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GMVD
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.06 million

Miscellaneous

Free Float
1,235,000
Market Cap
$3.88 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Yacov Geva (Age 72)
    Pres, CEO, MD & Exec. Director
    Comp: $360k
  • Mr. Igor Bluvstein
    Chief Financial Officer
  • Mr. Benny Tal (Age 63)
    VP of R&D and CTO
  • Mr. Oded Shahar (Age 62)
    Sr. Investment Banker and Sr. VP of Merger & Acquisition
  • Ms. Dror Nuriel-Roth (Age 47)
    Exec. VP of US Operations
  • Mr. Kobi Ben Efraim (Age 67)
    Controller
  • Mr. Brett Tucker
    Company Sec.













GMVD Stock - Frequently Asked Questions

How have GMVD shares performed in 2023?

G Medical Innovations' stock was trading at $3.28 at the start of the year. Since then, GMVD stock has decreased by 39.6% and is now trading at $1.98.
View the best growth stocks for 2023 here
.

When is G Medical Innovations' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our GMVD earnings forecast
.

When did G Medical Innovations IPO?

(GMVD) raised $8 million in an initial public offering on Friday, June 25th 2021. The company issued 3,000,000 shares at a price of $5.00-$0.00 per share.

What is G Medical Innovations' stock symbol?

G Medical Innovations trades on the NASDAQ under the ticker symbol "GMVD."

Who are G Medical Innovations' major shareholders?

G Medical Innovations' stock is owned by many different retail and institutional investors. Top institutional shareholders include Regal Partners Ltd (0.78%).

How do I buy shares of G Medical Innovations?

Shares of GMVD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is G Medical Innovations' stock price today?

One share of GMVD stock can currently be purchased for approximately $1.98.

How much money does G Medical Innovations make?

G Medical Innovations (NASDAQ:GMVD) has a market capitalization of $3.88 million and generates $5.06 million in revenue each year.

How can I contact G Medical Innovations?

G Medical Innovations' mailing address is 5 OPPENHEIMER ST., REHOVOT L3, 7670105. The official website for the company is gmedinnovations.com. The company can be reached via phone at 972-8958-4777.

This page (NASDAQ:GMVD) was last updated on 3/25/2023 by MarketBeat.com Staff